View Author
plasma cholesterol activity transfer study protein subject cholesteryl level lipid effect diabetes ester hdl cholesterol lipoprotein patient triglycerides plasma pltp activity cholesterol ef flux concentration insulin pltp activity phospholipid phospholipid transfer protein apolipoprotein van tol atherosclerosi type 2 diabetes relationship lipoproteins disease analysis treatment table blood change adiponectin lcat activity university density baseline particle insulin resistance plasma lcat activity dullaart cholesteryl ester transfer atorvastatin torcetrapib value group netherland metabolism apo a-i groningen blood pressure pressure control type 2 association cholesterol transport glucose leptin formation plasma triglycerides regression analysis polymorphism resistance ͻ0.001 plasma cet swets subs service pltp gene score mellitu density lipoproteins regression decrease insulin sensitivity lecithin lp-pla acyltransferase cholesterol efflux
10 Most Recent Publications
|
Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: Possible contribution to an atherogenic lipoprotein profile
(Article)
Dullaart, R.P.F. Constantinides, A. Perton, F.G. Van Leeuwen, J.J.J. Van Pelt, J.L. Vries, R. de Tol, A. van |
2011-05-01
|
|
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(Article)
Kappelle, P.J.W.H. Ahnström, J. Dikkeschei, B.D. Vries, R. de Sluiter, W.J. Wolffenbuttel, B.H.R. Tol, A. van Nielsen, L.B. Dahlbäck, B. Dullaart, R.P.F. |
2010-11-01
|
|
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility
(Article)
Vergeer, M. Boekholdt, S.M. Hofman, A. Uitterlinden, A.G. Duijn, C.M. van Witteman, J.C.M. Jukema, J.W. Schadt, E.E. Schoot, E. van der Kastelein, J.J. Khaw, K-T. Dullaart, R.P.F. Sandhu, M.S. Tol, A. van Trip, M.D. Dallinga-Thie, G.M. Ricketts, S.L. Wareham, N.J. Brown, M.J. Faire, U.D. Leander, K. Gigante, B. Kavousi, M. |
2010-08-03
|
|
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms
(Article)
Sofat, R. Hingorani, A. Wareham, N.J. Khaw, K-T. Kumari, M. Kivimaki, M. Marmot, M. Asselbergs, F.W. Harst, P. van der Dullaart, R.P.F. Navis, G. Veldhuisen, D.J. van Smeeth, L. Gilst, W.H. van Thompson, J.F. McCaskie, P. Palmer, C. Arca, M. Quagliarini, F. Gaudio, C. Cambien, F. Nicaud, V. Poirer, O. Humphries, S.E. Gudnason, V. Isaacs, A. Witteman, J.C.M. Tikka-Kleemola, P. Pencina, M. Vasan, R.S. D'Agostino, R.B. Ordovas, J.M. Li, T.Y. Kakko, S. Talmud, P.J. Kauma, H. Savolainen, M.J. Kesäniemi, Y.A. Sandhofer, A. Paulweber, B. Sorli, J.V. Goto, A. Yokoyama, S. Okumura, K. Horne, B.D. Cooper, J. Packard, C. Freeman, D. Ford, I. Sattar, N. McCormack, V. Lawlor, D.A. Ebrahim, S. Smith, G.D. Kastelein, J.J. Deanfield, J. Shah, T. Casas, J.P. Sandhu, M.S. Ricketts, S.L. Boekholdt, S.M. |
2010-01-01
|
|
Plasma lecithin:cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men
(Article)
Dullaart, R.P.F. Perton, F.G. Kappelle, P.J.W.H. Vries, R. de Sluiter, W. Tol, A. van |
2010-01-01
|
|
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
(Article)
Dallinga-Thie, G.M. Tol, A. van Dullaart, R.P.F. |
2009-08-01
|
|
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: Modification by triglycerides and cholesteryl ester transfer protein
(Article)
Kappelle, P.J.W.H. Zwang, L. Huisman, M.V. Banga, J.D. Sluiter, W. Dallinga-Thie, G.M. Dullaart, R.P.F. |
2009-07-01
|
|
Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus
(Article)
Dullaart, R.P.F. Vries, R. de Voorbij, H.A.M. Sluiter, W.J. Tol, A. van |
2009-03-01
|
|
Plasma lecithin: Cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness
(Article)
Dullaart, R.P.F. Perton, F.G. Sluiter, W. Vries, R. de Tol, A. van |
2008-12-01
|
|
Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases
(Article)
Dullaart, R.P.F. Vries, R. de Dallinga-Thie, G.M. Sluiter, W. Tol, A. van |
2008-03-01
|
